KEGG   DRUG: Trifluridine - tipiracil hydrochloride mixtHelp
Entry
D10526            Mixture   Drug                                   

Name
Trifluridine - tipiracil hydrochloride mixt;
Lonsurf (TN)
Product
Component
Trifluridine [DR:D00391], Tipiracil hydrochloride [DR:D10467]
Remark
Therapeutic category: 4299
ATC code: L01BC59
Product: D10526<JP/US>
Efficacy
Antineoplastic
  Disease
Colorectal cancer [DS:H00020]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01B ANTIMETABOLITES
    L01BC Pyrimidine analogues
     L01BC59 Trifluridine, combinations
      D10526  Trifluridine - tipiracil hydrochloride mixt <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Antineoplastics, Other
   Tiperacil/Trifluridine
    D10526  Trifluridine - tipiracil hydrochloride mixt
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4299  Others
     D10526  Trifluridine - tipiracil hydrochloride mixt
Antineoplastics [br08340.html]
 D10526
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D10526
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10526
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10526
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10526
BRITE hierarchy
Other DBs
PubChem: 254741488
ChEBI: 90876
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system